AN2 Therapeutics, Inc. (ANTX)
4.59
-0.06
(-1.29%)
USD |
NASDAQ |
May 07, 16:00
4.50
-0.09
(-1.96%)
After-Hours: 20:00
AN2 Therapeutics Free Cash Flow : -29.83M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Relmada Therapeutics, Inc. | -45.79M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Savara, Inc. | -101.06M |
| BioMarin Pharmaceutical, Inc. | 759.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.236M |
| Cash from Investing (Quarterly) | 7.174M |
| Free Cash Flow Per Share (Quarterly) | -0.1725 |
| Free Cash Flow to Equity (Quarterly) | -5.236M |
| Free Cash Flow to Firm (Quarterly) | -5.236M |
| Free Cash Flow Yield | -21.51% |